Cardiac resynchronization therapy (CRT) has shown benefits in patients with end-stage
heart failure, depressed left ventricular (LV) ejection fraction (≤ 35%), and prolonged QRS …

Cardiac resynchronization therapy (CRT) has become an integrated treatment option for
patients with drug-refractory heart failure. Selection of patients for CRT is based on …

Cardiac resynchronization therapy (CRT) is now a well-recognized therapeutic option for
patients with end-stage heart failure. However, not all patients respond to CRT, and …

Left ventricular (LV) dyssynchrony is an increasingly important consideration in the
evaluation and management of patients with LV systolic dysfunction. Improvements in …

Aims The limitation of QRS duration as a surrogate measure for left ventricular (LV)
mechanical dyssynchrony (LVMD) in cardiac resynchronization therapy (CRT) patient …

Background—There are ongoing efforts to optimize patient selection criteria for cardiac
resynchronization therapy (CRT). In this regard, the relationship between acute change in …

Cardiac resynchronisation therapy (CRT) has an established role in the management of
patients with heart failure, reduced left ventricular ejection fraction (LVEF< 35%) and …

Background Placing the left ventricular (LV) lead in a viable segment with the latest
mechanical activation (vSOLA) may be associated with optimal cardiac resynchronization …

Cardiac resynchronization therapy (CRT) is an established therapy for patients with
advanced heart failure, depressed left ventricular function, and wide QRS complex …

Cardiac resynchronization therapy (CRT) is a novel therapy for patients with refractory heart
failure (HF). Large clinical trials evaluating CRT have demonstrated significant …